| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Laboratories of the Medical Research Council of Ireland, Trinity College, Dublin, Ireland
Methylglyoxal-1-thiosemicarbazone-2-N4-substituted thiosemicarbazones (A isomers) and the isomeric 1-N4-substituted thiosemicarbazones-2-thiosemicarbazone (B isomers) have been synthesized as anticancer agents. A number of these compounds show high antitumor activity against Sarcoma 180 in the mouse. The most active compounds are those in which the N4-substitutent is methyl, ethyl, or n-propyl. The antiumor activity is not antagonized by pyridoxine.
1 This work was supported financially by May and Baker Ltd., Dagenham, Essex; Arthur Guinness Son & Co. (Dublin) Ltd.; Irish Hospital Sweepstakes Ltd.; Irish Hospitals Trust Ltd.; The Children's Cancer Research Foundation Inc., Boston; Conquer Cancer Campaign (Ireland); Southern Chemicals Ltd., Askeaton; Roadstone Ltd.; Carbide Ltd., Collooney; Rathdrum Parish Church (per Canon R. K. W. Lowe); T. W. Breaden, F.I.C.I.
Received 2/14/66.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |